BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 21839691)

  • 1. The knock-down of ERCC1 but not of XPF causes multinucleation.
    Rageul J; Frëmin C; Ezan F; Baffet G; Langouët S
    DNA Repair (Amst); 2011 Sep; 10(9):978-90. PubMed ID: 21839691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mislocalization of XPF-ERCC1 nuclease contributes to reduced DNA repair in XP-F patients.
    Ahmad A; Enzlin JH; Bhagwat NR; Wijgers N; Raams A; Appledoorn E; Theil AF; J Hoeijmakers JH; Vermeulen W; J Jaspers NG; Schärer OD; Niedernhofer LJ
    PLoS Genet; 2010 Mar; 6(3):e1000871. PubMed ID: 20221251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional and physical interactions between ERCC1 and MSH2 complexes for resistance to cis-diamminedichloroplatinum(II) in mammalian cells.
    Lan L; Hayashi T; Rabeya RM; Nakajima S; Kanno Si; Takao M; Matsunaga T; Yoshino M; Ichikawa M; Riele Ht; Tsuchiya S; Tanaka K; Yasui A
    DNA Repair (Amst); 2004 Feb; 3(2):135-43. PubMed ID: 14706347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ERCC1-XPF targeting to psoralen-DNA crosslinks depends on XPA and FANCD2.
    Sabatella M; Pines A; Slyskova J; Vermeulen W; Lans H
    Cell Mol Life Sci; 2020 May; 77(10):2005-2016. PubMed ID: 31392348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of mouse ERCC1 results in a novel repair syndrome with growth failure, nuclear abnormalities and senescence.
    Weeda G; Donker I; de Wit J; Morreau H; Janssens R; Vissers CJ; Nigg A; van Steeg H; Bootsma D; Hoeijmakers JH
    Curr Biol; 1997 Jun; 7(6):427-39. PubMed ID: 9197240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xeroderma pigmentosum group F protein binds to Eg5 and is required for proper mitosis: implications for XP-F and XFE.
    Tan LJ; Saijo M; Kuraoka I; Narita T; Takahata C; Iwai S; Tanaka K
    Genes Cells; 2012 Mar; 17(3):173-85. PubMed ID: 22353549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of XPF-ERCC1 enhances cisplatin efficacy in cancer cells.
    Arora S; Kothandapani A; Tillison K; Kalman-Maltese V; Patrick SM
    DNA Repair (Amst); 2010 Jul; 9(7):745-53. PubMed ID: 20418188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERCC1-XPF endonuclease facilitates DNA double-strand break repair.
    Ahmad A; Robinson AR; Duensing A; van Drunen E; Beverloo HB; Weisberg DB; Hasty P; Hoeijmakers JH; Niedernhofer LJ
    Mol Cell Biol; 2008 Aug; 28(16):5082-92. PubMed ID: 18541667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repair synthesis step involving ERCC1-XPF participates in DNA repair of the Top1-DNA damage complex.
    Takahata C; Masuda Y; Takedachi A; Tanaka K; Iwai S; Kuraoka I
    Carcinogenesis; 2015 Aug; 36(8):841-51. PubMed ID: 26025908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interstrand crosslink repair: can XPF-ERCC1 be let off the hook?
    Bergstralh DT; Sekelsky J
    Trends Genet; 2008 Feb; 24(2):70-6. PubMed ID: 18192062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. XPF knockout via CRISPR/Cas9 reveals that ERCC1 is retained in the cytoplasm without its heterodimer partner XPF.
    Lehmann J; Seebode C; Smolorz S; Schubert S; Emmert S
    Cell Mol Life Sci; 2017 Jun; 74(11):2081-2094. PubMed ID: 28130555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF beta promotes repair of bulky DNA damage through increased ERCC1/XPF and ERCC1/XPA interaction.
    Zheng H; Jarvis IWH; Bottai M; Dreij K; Stenius U
    Carcinogenesis; 2019 Jun; 40(4):580-591. PubMed ID: 30418489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the ERCC1-XPF structure-specific endonuclease to overcome cancer chemoresistance.
    McNeil EM; Astell KR; Ritchie AM; Shave S; Houston DR; Bakrania P; Jones HM; Khurana P; Wallace C; Chapman T; Wear MA; Walkinshaw MD; Saxty B; Melton DW
    DNA Repair (Amst); 2015 Jul; 31():19-28. PubMed ID: 25956741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple roles of the ERCC1-XPF endonuclease in DNA repair and resistance to anticancer drugs.
    Kirschner K; Melton DW
    Anticancer Res; 2010 Sep; 30(9):3223-32. PubMed ID: 20944091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The age-related expression decline of ERCC1 and XPF for forensic age estimation: A preliminary study.
    Deng XD; Gao Q; Zhang W; Zhang B; Ma Y; Zhang LX; Muer C; Xie Y; Liu Y
    J Forensic Leg Med; 2017 Jul; 49():15-19. PubMed ID: 28486142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ERCC1 and ERCC4 (XPF) genes and gene products.
    Manandhar M; Boulware KS; Wood RD
    Gene; 2015 Sep; 569(2):153-61. PubMed ID: 26074087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Cerebro-oculo-facio-skeletal Syndrome Point Mutation F231L in the ERCC1 DNA Repair Protein Causes Dissociation of the ERCC1-XPF Complex.
    Faridounnia M; Wienk H; Kovačič L; Folkers GE; Jaspers NG; Kaptein R; Hoeijmakers JH; Boelens R
    J Biol Chem; 2015 Aug; 290(33):20541-55. PubMed ID: 26085086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping of interaction domains between human repair proteins ERCC1 and XPF.
    de Laat WL; Sijbers AM; Odijk H; Jaspers NG; Hoeijmakers JH
    Nucleic Acids Res; 1998 Sep; 26(18):4146-52. PubMed ID: 9722633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The formation of UV-induced chromosome aberrations involves ERCC1 and XPF but not other nucleotide excision repair genes.
    Chipchase MD; Melton DW
    DNA Repair (Amst); 2002 Apr; 1(4):335-40. PubMed ID: 12509251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple DNA binding domains mediate the function of the ERCC1-XPF protein in nucleotide excision repair.
    Su Y; Orelli B; Madireddy A; Niedernhofer LJ; Schärer OD
    J Biol Chem; 2012 Jun; 287(26):21846-55. PubMed ID: 22547097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.